Sandra Herder

Sandra Herder has extensive experience in regulatory affairs and operations in the pharmaceutical industry. Sandra is currently serving as the Director of Regulatory Operations at EyeBio since February 2023. Prior to this, they worked at Oyster Point Pharma as the Director of Regulatory Operations from January 2022 to July 2022, and as the Senior Manager of Regulatory Affairs from August 2020 to December 2021.

Before joining Oyster Point Pharma, Sandra was employed at Taiho Oncology, Inc. as the Senior Manager of Regulatory Operations from January 2020 to August 2020, and as the Manager of Regulatory Affairs Operations from March 2018 to January 2020.

Sandra also held positions at The Medicines Company, serving as the Director of Regulatory Operations from June 2013 to March 2018, and as the Senior Manager of Regulatory Operations from March 2012 to June 2013.

Earlier in their career, Sandra worked at Merck as the Senior Manager of Regulatory Affairs from February 2008 to March 2011, at Novartis Pharmaceuticals as the Electronic Submission Manager from August 2005 to February 2008, at Eyetech Pharmaceuticals as the Senior Regulatory Associate from March 2004 to July 2005, and at Schering-Plough Corporation as the Submissions Supervisor from August 1989 to March 2004.

Sandra Herder's education history includes attending the University of Phoenix, although no specific details regarding the degree or field of study are provided.